These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 7905275

  • 1. Pharmacologic management of heart failure: neurohormonal agents.
    Moser DK.
    Crit Care Nurs Clin North Am; 1993 Dec; 5(4):599-608. PubMed ID: 7905275
    [Abstract] [Full Text] [Related]

  • 2. Mechanistic and clinical rationales for using beta-blockers in heart failure.
    Bristow MR.
    J Card Fail; 2000 Jun; 6(2 Suppl 1):8-14. PubMed ID: 10908093
    [Abstract] [Full Text] [Related]

  • 3. Managing the patient with diabetes mellitus and heart failure: issues and considerations.
    Fonarow GC.
    Am J Med; 2004 Mar 08; 116 Suppl 5A():76S-88S. PubMed ID: 15019865
    [Abstract] [Full Text] [Related]

  • 4. Interaction of beta-blockers and angiotensin receptor blockers/ACE inhibitors in heart failure.
    Cohn JN.
    J Renin Angiotensin Aldosterone Syst; 2003 Sep 08; 4(3):137-9. PubMed ID: 14608516
    [Abstract] [Full Text] [Related]

  • 5. [Recent advances and limitations of medical treatment on heart failure].
    Momomura S.
    Kyobu Geka; 2007 Jun 08; 60(6):484-7. PubMed ID: 17564066
    [Abstract] [Full Text] [Related]

  • 6. ACE inhibitors and beta blockers in chronic congestive cardiac failure: therapeutic basis.
    Manoria PC, Manoria P.
    J Indian Med Assoc; 2003 May 08; 101(5):311-2, 315. PubMed ID: 14575221
    [Abstract] [Full Text] [Related]

  • 7. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
    McMurray JJ, Pfeffer MA, Swedberg K, Dzau VJ.
    Circulation; 2004 Nov 16; 110(20):3281-8. PubMed ID: 15545527
    [No Abstract] [Full Text] [Related]

  • 8. Neurohormonal antagonism in heart failure: what is the optimal strategy?
    Sackner-Bernstein JD, Hart D.
    Mt Sinai J Med; 2004 Mar 16; 71(2):115-26. PubMed ID: 15029403
    [Abstract] [Full Text] [Related]

  • 9. Neurohormonal activation and the response to converting enzyme inhibitors in congestive heart failure.
    Kubo SH.
    Circulation; 1990 Feb 16; 81(2 Suppl):III107-14. PubMed ID: 2137052
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Neurohormonal factors in heart failure (and III)].
    Cosín Aguilar J, Cruz Fernández JM, de Teresa Galván E, Ferreira Montero IJ, López-Sendón J, Soler Soler J, Tamargo Menéndez J.
    Rev Esp Cardiol; 1996 Jun 16; 49(6):405-22. PubMed ID: 8753906
    [Abstract] [Full Text] [Related]

  • 13. Combination neurohormonal blockade with ACE inhibitors, angiotensin II antagonists and beta-blockers in patients with congestive heart failure: design of the Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot Study.
    Tsuyuki RT, Yusuf S, Rouleau JL, Maggioni AP, McKelvie RS, Wiecek EM, Wang Y, Pogue J, Teo KK, White M, Avezum A, Latini R, Held P, Lindgren E, Probstfield J.
    Can J Cardiol; 1997 Dec 16; 13(12):1166-74. PubMed ID: 9444298
    [Abstract] [Full Text] [Related]

  • 14. Heart failure: recent advances in prevention and treatment.
    Fonarow GC.
    Rev Cardiovasc Med; 2000 Dec 16; 1(1):25-33, 54. PubMed ID: 12457149
    [Abstract] [Full Text] [Related]

  • 15. Treatments that improve outcome in the patient with heart failure, left ventricular systolic dysfunction, or both after acute myocardial infarction.
    Weir R, McMurray JJ.
    Heart; 2005 May 16; 91 Suppl 2(Suppl 2):ii17-20; discussion ii31, ii43-8. PubMed ID: 15831602
    [Abstract] [Full Text] [Related]

  • 16. New concepts in post-infarction ventricular remodeling.
    Udelson JE, Patten RD, Konstam MA.
    Rev Cardiovasc Med; 2003 May 16; 4 Suppl 3():S3-12. PubMed ID: 14564229
    [Abstract] [Full Text] [Related]

  • 17. Implications of heart failure drug trials: COMET, CHARM, EPHESUS.
    Hiestand B, Abraham WT.
    Rev Cardiovasc Med; 2005 May 16; 6 Suppl 2():S4-11. PubMed ID: 15891699
    [Abstract] [Full Text] [Related]

  • 18. [Inhibition of renin-angiotensin-aldosterone system: what evidence?].
    Mota T.
    Rev Port Cardiol; 2001 Mar 16; 20 Suppl 3():13-5. PubMed ID: 11409069
    [Abstract] [Full Text] [Related]

  • 19. Limitations of current medical therapies for the treatment of heart failure.
    Miller LW.
    Rev Cardiovasc Med; 2003 Mar 16; 4 Suppl 2():S21-9. PubMed ID: 12776010
    [Abstract] [Full Text] [Related]

  • 20. Blockade of the renin-angiotensin system. Effect on mortality in patients with left ventricular systolic dysfunction.
    Pitt B.
    Cardiol Clin; 1994 Feb 16; 12(1):101-14. PubMed ID: 8181019
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.